Benjamin Stone
Chief Business Officer · First Tracks Biotherapeutics, Inc.
Individual
- 2026
- Aug 18, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Benjamin Stone files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $65.00M in TRAX purchases and sales in the last 12 months
- J. Anthony Ware - $1.76M in TRAX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Benjamin Stone?
Benjamin Stone is a corporate insider, tracked as Chief Business Officer of First Tracks Biotherapeutics, Inc. (TRAX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Benjamin Stone submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.